PharmaForce 2018

September 26-September 28, 2018

The Westin Copley Place, Boston, MA

Contact Us: 1.888.482.6012

Speaker

Kent Rogers
Kent Rogers
SVP, Industry Relations, OptumRX
UnitedHealth Group
Kent currently serves as the Senior Vice President, Industry Relations for OptumRx with responsibility for formulary and procurement contracting for all books of business on behalf of internal and external clients of United Health Group. OptumRx is the pharmacy benefit management division of Optum servicing over 66 million members and processing over 1 billion pharmacy claims which represent over $80 billion in drug spend.

He has more than 25 years of experience with the pharmaceutical industry, focusing primarily on payer, channel and patient services strategies. Prior to OptumRx, Kent was a Principal Consultant with Blue Fin Group, served as the Vice President of Managed Markets at Acorda Therapeutics, and held various positions of increasing responsibility within Sales and Managed Markets at Schering Plough and Merck. His career experience includes business development, health economics/outcomes research, building and leading market access teams, developing and implementing payer access and channel strategies, and launching patient services programs.

Kent has a Bachelor of Science in Business Management from Indiana University, and an MBA from Emory University’s Goizueta School of Business.
Bharti Rai
Bharti Rai
Chief Commercial Data Officer
Bayer
Jon Zwinski
Jon Zwinski
SVP, Sales
Chiesi
Adam Houston
Adam Houston
Head, Customer Engagement & Marketing Innovation
Takeda Pharmaceuticals
John Alter
John Alter
VP, Patient & Health Impact, Pfizer Essential Health Business Unit
Pfizer
John is currently Vice President, Global Health and Value for Pfizer’s Essential Health business unit, which has worldwide sales of more than $20B from a portfolio of over 700 molecules including biosimilars, sterile injectables and solid oral dosage forms. The portfolio is the result of Pfizer’s research and development as well as from the acquisitions of Warner Lambert, Pharmacia and Upjohn, Wyeth and most recently Hospira. Pfizer is the world’s leading biosimilars company based on audited sales and its portfolio of biosimilar molecules is for the treatment of inflammation, oncology and supportive care.

Pfizer’s Global Health and Value team covers the functions of Pricing, Access, Reimbursement, Health Economics, Outcomes Research and Real World Data. John has been with Pfizer for over 18 years in multiple roles of increasing responsibilities, the last three years in his current role. He has presented at several biosimilars conferences on the topic of pricing and access and in 2016 was a guest lecturer on the subject of HEOR at Kings College London as part of the International Federation of Association of Pharmaceutical Physicians.
Mike Moran
Mike Moran
VP, Sales
Eagle Pharmaceuticals
Riad Dirani
Riad Dirani
VP, Global HEOR
Teva Pharmaceuticals
Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and commercialization of Teva’s portfolio of products and offerings globally.

Riad has worked in the pharmaceutical industry since 2000, including positions of increasing responsibility at Aventis, GlaxoSmithKline, Pfizer, and Johnson & Johnson in multiple therapeutic areas. Riad joined Teva in 2014 to build the HEOR group and establish it operating model.
Riad received his Ph.D. in Health Services Research/Health Economics from The Pennsylvania State University. He has published over 25 journal articles and made numerous presentations to professional organizations, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and therapeutic-specific conferences.
Jim Lefevere
Jim Lefevere
Director, Marketing Strategy & Services
Roche
Jim Lefevere is an award-winning marketing leader and innovative global marketing and commercial operations professional in consumer goods, health care, and medical devices. He combines senior marketing experience with a pioneering entrepreneurial vision. Named one of the Top Forty business professionals under 40 by the Indianapolis Business Journal, He has lead marketing efforts for Fortune 100 organizations, industry consortium and fast growth start-ups. A respected expert on digital marketing and health care, he has been called a Social Media Pioneer and a Digital Health Scholar. His focus is on creating marketing and digital strategies that connect, engage and make a difference. He currently heads global marketing strategy and services along with digital marketing for a division of the world’s largest bio-tech company and a leader in research driven health care.
Michael Lombard
Michael Lombard
Hospital CEO
Cornerstone Health
Lawrence Bressler
Lawrence Bressler
Senior Director, US Launch Lead- Rare Disease
Shire
Paul Darling
Paul Darling
Principal
ZS Associates
Paul Darling is a Principal with ZS Associates in the firm’s San Francisco office. Paul assists life sciences companies in evaluating new markets, acquisitions, and licensing opportunities as well as developing the associated go-to-market strategies. He has presented at several industry conferences on the topics of forecasting, asset valuation, and alliance structuring.

Paul developed and leads ZS's Institute on U.S. Healthcare Evolution and Scenario Planning. He is currently exploring opportunities for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform, including new business models, therapies, acquisitions, and partnerships, as well as reimagining the commercial model to support such portfolio changes.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in Statistical Thermodynamics from Washington University.
John Santaferraro
John Santaferraro
Chief Analytics Officer
Educational Measures, LLC
John Santaferraro is the chief analytics officer at Educational Measures. With 20 years of experience as a big data analytics imagineer, he is responsible for driving the next-generation of meeting and event analytics. Previously, he was the interim CMO at Diyotta and vice president of marketing at ParAccel until it was purchased by Actian, where he stayed in that position to help guide the transition. He began his career in technology as the co-founder of a data warehouse software startup that eventually sold to Teradata. Along the way he has held executive big data marketing positions in top tech companies including Tandem, Compaq, and HP. When he’s not hiking, skiing, or snowshoeing in the Colorado Rockies, John loves to cook gourmet, collect fine wine, and brew craft beer.
John  Vitti
John Vitti
Executive Director, Commercial Process Optimization
Sunovion Pharmaceuticals
Charleen Ring
Charleen Ring
Program Director
PharmaForce
Charleen is an experienced content director, market researcher and published author with a passion for creative storytelling. She produces innovative b2b networking conferences that serve as platforms to help businesses and professionals create narratives that inspire and foster connectivity between industry thought leaders. Her portfolio currently focuses on events in the life sciences and travel, hospitality and leisure industries. She manages WBR’s Digital Travel Summit, PharmaForce, MedForce, and NGPX. When not developing awesome programs, you can find her working on her next novel, traveling with her husband, or Instagramming photos of her beloved French Bulldog, Marv.

We're always looking ahead to book a roster of inspiring speakers. Contact us today to reserve your spot.

Want to see who spoke previously? Check out the link below.

View 2017 Speakers
    Live Chat Software